4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,155.00p
   
  • Change Today:
      35.00p
  • 52 Week High: 1,820.00
  • 52 Week Low: 950.00
  • Currency: UK Pounds
  • Shares Issued: 15.50m
  • Volume: 2,420
  • Market Cap: £178.98m
  • Beta: 0.02

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
86.18% above the market average86.18% above the market average86.18% above the market average86.18% above the market average86.18% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
97.35% above the market average97.35% above the market average97.35% above the market average97.35% above the market average97.35% above the market average
92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average
Price Book Ratio Not Available

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
72.57% above the market average72.57% above the market average72.57% above the market average72.57% above the market average72.57% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Price Chg 3m
6.12% below the market average6.12% below the market average6.12% below the market average6.12% below the market average6.12% below the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
77.49% above the market average77.49% above the market average77.49% above the market average77.49% above the market average77.49% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average
Momentum 20
94.84% above the market average94.84% above the market average94.84% above the market average94.84% above the market average94.84% above the market average
95.56% above the sector average95.56% above the sector average95.56% above the sector average95.56% above the sector average95.56% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
93.52% below the market average93.52% below the market average93.52% below the market average93.52% below the market average93.52% below the market average
77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
45.97% below the market average45.97% below the market average45.97% below the market average45.97% below the market average45.97% below the market average
31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
86.88% below the market average86.88% below the market average86.88% below the market average86.88% below the market average86.88% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Operating Profit Loss
80.9% below the market average80.9% below the market average80.9% below the market average80.9% below the market average80.9% below the market average
36.17% below the sector average36.17% below the sector average36.17% below the sector average36.17% below the sector average36.17% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
52.8% below the market average52.8% below the market average52.8% below the market average52.8% below the market average52.8% below the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average
Cash
33.43% below the market average33.43% below the market average33.43% below the market average33.43% below the market average33.43% below the market average
17.39% below the sector average17.39% below the sector average17.39% below the sector average17.39% below the sector average17.39% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
15.69% above the market average15.69% above the market average15.69% above the market average15.69% above the market average15.69% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Buys 1y
69.82% above the market average69.82% above the market average69.82% above the market average69.82% above the market average69.82% above the market average
48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,155.00p
Change Today 35.00p
% Change 3.13 %
52 Week High 1,820.00
52 Week Low 950.00
Volume 2,420
Shares Issued 15.50m
Market Cap £178.98m
Beta 0.02

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.99% below the market average21.99% below the market average21.99% below the market average21.99% below the market average21.99% below the market average
23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average
Price Trend
62.09% above the market average62.09% above the market average62.09% above the market average62.09% above the market average62.09% above the market average
70.83% above the sector average70.83% above the sector average70.83% above the sector average70.83% above the sector average70.83% above the sector average
Income Not Available
Growth
38.10% above the market average38.10% above the market average38.10% above the market average38.10% above the market average38.10% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average

4basebio Dividends

No dividends found

Trades for 11-Apr-2025

Time Volume / Share Price
15:28 1,500 @ 1,150.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page